Chaffin Luhana Alerts Hip Patients to Stryker Rejuvenate Recall

Share Article

Chaffin Luhana alerts patients implanted with Stryker modular hip systems to a recent recall of the Rejuvenate and ABG II devices.

Chaffin Luhana LLP, a national plaintiffs-only law firm, alerts patients implanted with a Stryker Rejuvenate Modular and ABG II modular-neck hip stems to the recent announcement of a voluntary recall of these devices. According to the Stryker website, the company initiated the Stryker Rejuvenate recall due to the increased risk of metal corrosion and the associated tissue damage. Patients who may be experiencing pain, swelling, immobility, premature loosening, or other complications potentially requiring revision surgery, may be eligible for a Stryker Rejuvenate lawsuit.

Metal-on-metal hip devices, such as the recalled DePuy ASR, Zimmer Durom Cup, and Wright Profemur hips, have come under fire in recent years because of the tendency for metal components to rub against one another, depositing shards of chromium and cobalt into the patient's tissues and bloodstream. According to a recent study published in The Lancet, failure rates for these devices is six percent, compared to only 1.7–2.3 percent observed in other types of implants. Researchers concluded: "Metal-on-metal stemmed articulations give poor implant survival compared with other options and should not be implanted."

The British Medical Journal also published an article in February 2012 noting that some of these devices release metal ions on a much greater scale than previously thought, and that these ions can "seep into local tissue causing reactions that destroy muscle and bone and leave some patients with long term disability."

The Stryker modular stem hip implants were not considered true metal-on-metal implants initially, because they contain a ceramic component and do not place a metal ball against a metal socket. They do, however, place a metal femoral stem against a separate metal neck. Unlike other hip systems that have a fixed length, one-piece femoral stem, the Stryker has several mix-and-match stem and neck components to give the surgeon more options. The problem occurs when the metal neck and stem come under stress, such as that experienced in an actual patient. This stress creates wear on the metal-on-metal junction, increasing the risk of metallic debris.

In April 2012, Stryker Orthopedics issued an "Urgent Field Safety Notice" indicating that patients could potentially develop metallosis from the Rejuvenate Modular Hip Implant System, which could lead to complications like bone damage, immunological problems, significant pain, allergic reactions, tissue damage and death, and elevated blood levels of cobalt. In May 2012, Health Canada announced a Stryker Rejuvenate recall so the instructions for use could be updated. To date, the FDA has received over 60 adverse event reports related to these devices, with patients describing metal toxicity requiring revision surgery. These reports are believed to have contributed to Stryker's decision to recall these devices.

This most recent recall follows on the heels of another Stryker recall announced in April 2012, in which the company pulled the MITCH TRH modular head/acetabular cup from the New Zealand market due to higher revision rates than that of all other total hip implants.

Chaffin Luhana LLP has a long and successful history of protecting the rights of patients affected by defective drugs and medical devices. Partners Eric Chaffin and Roopal Luhana have represented high-profile cases in federal and state courts across the country. Though unable to guarantee results, the firm has a distinguished track record of success and is highly committed to each case.

If you or a loved one has suffered an injury allegedly caused by the Stryker Rejuvenate or ABG II modular-neck stems, contact a Stryker Rejuvenate lawyer at Chaffin Luhana LLP for a free and confidential case review at 1-888-480-1123, or visit their website at A Stryker Rejuvenate lawsuit may be able to help recover damages and ease the financial challenges of medical treatment.

Eric T. Chaffin, Esq.
600 Third Ave.
12th Floor
New York, New York 10016                                                                                                                                                
Toll Free Telephone: (888) 480-1123
Toll Free Fax: (888) 499-1123

Attorney Advertising. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Eric Chaffin
Visit website